For dental patients assessed as being moderate or high risk for type 2 diabetes, is direct referral or signposting more effective to facilitate contact with a health care professional?

ISRCTN ISRCTN16798215
DOI https://doi.org/10.1186/ISRCTN16798215
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Integrated Research Application System (IRAS) 306747
Protocol serial number Dental/VT/01, IRAS 306747
Sponsor NHS Education for Scotland
Funder NHS Education for Scotland
Submission date
31/03/2022
Registration date
30/08/2023
Last edited
31/08/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
It has been suggested in recent years by government policy documents such as the Oral Health Improvement Plan that patients could receive general health checks while attending their dental practice for a routine appointment. This study will use risk assessment for type 2 diabetes as an example of a general health check to investigate to compare the effectiveness of two referral strategies (direct referral and signposting) used by primary care dentists for facilitating contact between dental patients assessed as being at moderate or high risk of type 2 diabetes and a healthcare professional. The study will also explore the views and experiences of dental patients and dentists about the use of the risk assessment in a dental setting.

Who can participate?
Patients: Dental patients aged 40 years or older who attend a vocational dental training practice in Scotland can participate. They must be attending their dentist for a routine appointment.
Practitioners who work in a vocational dental training practice in Scotland can participate.

What does the study involve?
Eligible dental patients who attend an NHS dental practice for a routine appointment will be invited to take part. If eligible, consenting patients will be asked at this appointment to complete an online risk assessment tool provided by Diabetes UK. Participating dental practices will be randomly allocated to deliver either a direct referral or a signposting intervention to patients with a risk level of "high" or "moderate" to facilitate contact with a healthcare professional. One month later, all participating patients will be asked to complete an online questionnaire which will ask if they made contact with a healthcare professional - this is the main outcome measure of the study. They will also be asked about their experience of being risk assessed in a dental setting, how they felt about being told their risk level and their thoughts about doing risk assessments like this in a dental setting. Participating dentists will also be asked to complete an online questionnaire about their thoughts and experiences about using the risk assessment tool in a dental setting.

What are the possible benefits and risks of participating?
Possible benefits to participants include an increased knowledge of the risk factors of type 2 diabetes. Some patient participants may discover they are at moderate or high risk of developing type 2 diabetes by taking part in this study. This study will encourage these participants to speak to a healthcare professional, which may lead to timely and appropriate clinical investigation and treatment if needed.
Possible risks to participants include a risk that the risk assessment may incorrectly report a patient participant to be at a lower risk of type 2 diabetes when they may be at high risk. There is also a risk that patient participants may feel anxious or concerned about their risk assessment score.
There are no expected risks to practitioner participants.

Where is the study run from?
NHS Education for Scotland is managing the study (UK)

When is the study starting and how long is it expected to run for?
December 2021 to December 2022.

Who is funding the study?
This study is not funded by an external organisation. All costs incurred during the running of the study will be covered by NHS Education for Scotland (UK)

Who is the main contact?
Dr Laura Beaton, laura.beaton@nhs.scot

Contact information

Dr Laura Beaton
Public

NHS Education for Scotland
Dundee Dental Education Centre
Frankland Building
Small’s Wynd
Dundee
DD1 4HN
United Kingdom

ORCiD logoORCID ID 0000-0002-0417-5989
Phone +44 1382 740917
Email laura.beaton@nhs.scot
Dr Laura Beaton
Scientific

NHS Education for Scotland
Dundee Dental Education Centre
Frankland Building
Small’s Wynd
Dundee
DD1 4HN
United Kingdom

Phone +44 1382 740917
Email laura.beaton@nhs.scot
Dr Laura Beaton
Principal investigator

NHS Education for Scotland
Dundee Dental Education Centre
Frankland Building
Small’s Wynd
Dundee
DD1 4HN
United Kingdom

Phone +44 1382 740917
Email laura.beaton@nhs.scot

Study information

Primary study designInterventional
Study designMulti-centre two-arm clustered randomized controlled trial
Secondary study designCluster randomised trial
Participant information sheet 41470 PIS v3 08Mar2022 (patients).pdf
Scientific titleDRAMeRS: Diabetes Risk Assessment and Medical Referral or Signposting. A trial to compare the effectiveness of direct referral or signposting at facilitating contact between dental patients assessed as being at moderate or high risk of developing type 2 diabetes and a healthcare professional
Study acronymDRAMeRS
Study objectivesThe aim of the study is to compare the effectiveness of two referral strategies (direct referral and signposting) at facilitating contact between dental patients assessed as being at moderate or high risk of developing type 2 diabetes and a healthcare professional.
Ethics approval(s)Approved 15/03/2022, East of Scotland Research Ethics Service (Ninewells Hospital & Medical School, Tayside Medical Science Centre (TASC), Residency Block, Level 3, George Pirie Way, Dundee, DD1 9SY, UK; +44 (0)1382 383871; tay.eosres@nhs.scot), ref: 22/ES/0004
Health condition(s) or problem(s) studiedReferral strategies for dental patients at risk of type 2 diabetes
InterventionPractices will be randomised to either directly refer or signpost patients who have been risk assessed as being at moderate or high risk of type 2 diabetes to a healthcare professional. The study will randomise practices on a 1:1 basis.

If directly referred, a letter will be sent from the patient’s dentist to their GP practice. If signposted, the patient will receive a leaflet that provides information about type 2 diabetes and encourages them to contact a healthcare professional.

One month following the risk assessment, patients in both arms of the intervention, and those whose risk score was low or intermediate, will receive a follow-up questionnaire. Patients whose score was moderate or high will be asked if they have made contact with a healthcare professional. All participants will be asked about their thoughts and experiences of taking part in the study. Participating practitioners will also be asked to complete an online questionnaire about their thoughts and experiences of taking part in the study.
Intervention typeBehavioural
Primary outcome measure(s)

The proportion of dental patients assessed as being at moderate or high risk of type 2 diabetes who make contact with a healthcare professional. This proportion will be measured by follow-up questionnaire sent to participants one month following their assessment.

Key secondary outcome measure(s)

1. Beliefs of patients regarding the acceptability of the Diabetes UK Risk Assessment tool in a dental setting and their feelings about being told their risk level. Beliefs will be measured by follow-up questionnaire sent to participants one month following their assessment.
2. Beliefs of patients regarding the acceptability of the Diabetes UK Risk Assessment tool in a dental setting and their feelings about being told their risk level. Beliefs will be measured by follow-up questionnaire sent to participants one month following their assessment.

Completion date01/12/2022

Eligibility

Participant type(s)Mixed
Age groupAdult
Lower age limit40 Years
SexAll
Target sample size at registration140
Key inclusion criteriaPatients:
1. Male or female
2. Aged 40+ years
3. Attending a vocational dental training practice
4. Attending for a routine, non-emergency, appointment

Practitioners:
1. Male or female
2. Adults (18+ years)
3. Dentist in a vocational dental training practice
Key exclusion criteriaPatients:
1. Patients who do not meet inclusion criteria.
2. Patients who already have received a diagnosis of type 1 or type 2 diabetes.
3. Patients who are pregnant.

Practitioners:
1. Practitioners who do not meet inclusion criteria.
Date of first enrolment01/05/2022
Date of final enrolment30/07/2022

Locations

Countries of recruitment

  • United Kingdom
  • Scotland

Study participating centre

TRiaDS, Dental Clinical Effectiveness, NHS Education for Scotland
Dundee Dental Education Centre
Frankland Building
Small's Wynd
Dundee
DD1 4HN
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryData sharing statement to be made available at a later date
IPD sharing planThe data sharing statement will be provided at a later date.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet For patients
version 3
08/03/2022 25/04/2022 No Yes
Participant information sheet For practitioners
version 3
08/03/2022 25/04/2022 No Yes
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Study website Study website 11/11/2025 11/11/2025 No Yes

Additional files

41470 PIS v3 08Mar2022 (patients).pdf
For patients
41470 PIS v3 08Mar2022 (practicioners).pdf
For practitioners

Editorial Notes

31/08/2023: Internal review.
25/04/2022: Trial's existence confirmed by East of Scotland Research Ethics Service.